Pharmacological and clinical evaluation of GLP-1 receptor agonist——lixisenatideWANG Xue-yang, PEI Yi-fang, FENG Yu-fei, HU Xin1857-1860
Construction of competence model for GMP inspectors and empirical researchZHAO Zhen-yu, ZHOU Xia, WU Zhi-ang1861-1864
Interpretation and reflection on the Reg.(EU) No 536/2014 of the EuropeanWEI Fen-fang, SUN Yu-xin, LENG Jin-nuo, YANG Yue1865-1872
Study of enforcement of criminal liability for clinical investigator fraud under FDCAYUAN Li, YANG Yue1873-1879
Evolution and development of the expanded access of investigational new drugs in the United States of AmericaSUN Yu-xin, WEI Fen-fang, FENG Xiao-chan, YANG Yue1880-1886
Considerations on nonclinical pharmacology and toxicology studies of antibody-drug conjugates for oncologyYAN Li-ping, WANG Hai-xue, WANG Qing-li1894-1899
Toxicity of human papillomavirus vaccines for Wistar rats following repeated intramuscular administrationZHOU Xiao-bing, LIN Zhi, WANG Ya-jun, XU Lan, WANG Chao, HUANG Ying, JIANG Hua, MIAO Yu-fa, YANG Yan-wei, WANG Xue, YIN Fei, LIU Yong-jiang, CHEN Jian-ping, LI Bo1900-1905
Advances in preparation of mesoporous silica nanoparticles and its use as different functional drugYU Yue, TAO Chun, YANG Hai-yue, WANG Tian-yu, XUE Dan-ping, TIAN Xue-mei, ZHANG Mei-jing, FANG Sheng-nan, SONG Hong-tao1906-1912
PD-1/PD-L1 pathway in the development and treatment of tumors: a review of literatureCHE Zhang-hong1913-1917